Avidity Biosciences, Inc.

NASDAQ:RNA

28.46 (USD) • At close July 1, 2025
Bedrijfsnaam Avidity Biosciences, Inc.
Symbool RNA
Munteenheid USD
Prijs 28.46
Beurswaarde 3,430,511,480
Dividendpercentage 0%
52-weken bereik 21.51 - 56
Industrie Biotechnology
Sector Healthcare
CEO Ms. Sarah Boyce
Website https://www.aviditybiosciences.com

An error occurred while fetching data.

Over Avidity Biosciences, Inc.

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic muscle

Vergelijkbare Aandelen

Verve Therapeutics, Inc. logo

Verve Therapeutics, Inc.

VERV

11.28 USD

HealthStream, Inc. logo

HealthStream, Inc.

HSTM

27.73 USD

Aurora Cannabis Inc. logo

Aurora Cannabis Inc.

ACB

4.3 USD

Merus N.V. logo

Merus N.V.

MRUS

52.66 USD

Atea Pharmaceuticals, Inc. logo

Atea Pharmaceuticals, Inc.

AVIR

3.6 USD

Atai Life Sciences N.V. logo

Atai Life Sciences N.V.

ATAI

2.71 USD

InnovAge Holding Corp. logo

InnovAge Holding Corp.

INNV

3.95 USD

Nektar Therapeutics logo

Nektar Therapeutics

NKTR

24.59 USD

Codexis, Inc. logo

Codexis, Inc.

CDXS

2.4 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)